GWM
KALA icon

Greenwich Wealth Management’s KALA BIO KALA Stock Holding History

Greenwich Wealth Management’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-368
Closed -$3K – 311
2026
Q1 		$3K Buy
+368
New +$7.78K ﹤0.01% 307
2022
Q4 		– Sell
-12
Closed -$7K – 244
2022
Q3 		$7K Buy
12
+1
+9% +$785 ﹤0.01% 235
2022
Q2 		$8K Buy
11
+2
+22% +$3.14K ﹤0.01% 232
2022
Q1 		$31K Buy
9
+2
+29% +$5.24K ﹤0.01% 236
2021
Q4 		$20K Sell
7
-10
-59% -$46.4K ﹤0.01% 243
2021
Q3 		$113K Buy
17
+5
+42% +$43.2K 0.01% 236
2021
Q2 		$162K Buy
12
+3
+33% +$47.2K 0.01% 219
2021
Q1 		$156K Buy
9
+1
+13% +$19.5K 0.01% 199
2020
Q4 		$138K Buy
8
+1
+14% +$18.8K 0.01% 188
2020
Q3 		$139K Buy
7
+2
+40% +$46K 0.02% 184
2020
Q2 		$141K Sell
5
-2
-29% -$56.7K 0.03% 179
2020
Q1 		$148K Sell
7
-1
-13% -$16K 0.03% 173
2019
Q4 		$76K Buy
8
+2
+33% +$19.3K 0.02% 186
2019
Q3 		$53K Buy
6
+1
+20% +$12.2K 0.01% 177
2019
Q2 		$83K Buy
5
+1
+25% +$16.6K 0.01% 193
2019
Q1 		$84K Buy
+4
New +$71.1K 0.01% 185

Other funds holding KALA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Greenwich Wealth Management's KALA Position: Q2 2026 in Review

Greenwich Wealth Management sold out of KALA BIO (KALA) in Q2 2026, closing a stake of 368 shares — an estimated $3K sold.

Greenwich Wealth Management first reported a position in KALA in Q1 2019 and held it in 16 quarters. The position peaked at $162K in Q2 2021. 14 funds tracked by Wall St. Rank hold KALA as of Q2 2026.

  • Greenwich Wealth Management reported no remaining KALA BIO position as of Q2 2026 after selling out during the quarter.
  • Greenwich Wealth Management sold 368 KALA BIO shares in Q2 2026, an estimated $3K.
  • Greenwich Wealth Management first reported a position in KALA BIO in Q1 2019 and held it in 16 quarters.
  • Greenwich Wealth Management's KALA BIO position peaked at $162K in Q2 2021.
  • 14 funds tracked by Wall St. Rank held KALA BIO as of Q2 2026.

Based on Greenwich Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.